Skip to main content

Table 1 Clinical data and intraoperative variables of patients

From: Effects of lidocaine, dexmedetomidine, and their combination infusion on postoperative nausea and vomiting following laparoscopic hysterectomy: a randomized controlled trial

 

Group C (n = 60)

Group L (n = 60)

Group D (n = 60)

Group LD (n = 60)

P-value

Age (yr)

47.2 ± 5.1

45.4 ± 3.8

46.1 ± 4.3

46.6 ± 4.4

0.629

BMI

23.0 ± 1.4

22.8 ± 1.4

22.7 ± 1.5

22.5 ± 1.3

0.747

Operation time (min)

110.9 ± 9.0

113.4 ± 9.8

109.9 ± 11.1

114.3 ± 11.7

0.079

Anesthesia time (min)

133.6 ± 11.5

134.2 ± 10.9

132.8 ± 11.1

135.4 ± 11.7

0.707

Blood loss (ml)

74.4 ± 18.5

72.3 ± 16.9

73.4 ± 16.4

71.9 ± 14.3

0.187

Intraoperative fluids (ml)

893.8 ± 155.0

855.4 ± 135.1

904.3 ± 155.9

900.0 ± 158.4

0.379

ASA I/II, n

42/18

32/28

36/24

38/22

0.300

History of PONV, n (%)

6 (10.0%)

5 (8.3%)

7 (11.7%)

5 (8.3%)

0.912

History of motion sickness, n (%)

16 (26.7%)

18 (30%)

13 (21.7%)

20 (33.3%)

0.529

Smoking, n (%)

4 (6.7%)

3 (5.0%)

2 (3.3%)

3 (5.0%)

0.873

Intraoperative awareness, n (%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

 

Apfel score for PONV risk, n (%)

 1

0 (0%)

0 (0%)

0 (0%)

0 (0%)

 

 2

3 (5.0%)

2 (3.3%)

1 (1.7%)

3 (5.0%)

0.736

 3

36 (60.0%)

39 (65.0%)

34 (56.7%)

41 (68.3%)

0.560

 4

21 (35.0%)

19 (31.7%)

25 (41.7%)

16 (26.7%)

0.364

Use of propofol (mg·kg−1·h−1)

5.5 ± 0.4

5.4 ± 0.3

4.9 ± 0.3*✩

4.4 ± 0.2*✩#

 < 0.001

Use of remifentanil (μg·kg−1·h−1)

9.8 ± 0.6

9.4 ± 0.5*

5.7 ± 0.8*✩

5.3 ± 0.6*✩#

 < 0.001

  1. Data are present as mean ± standard deviation or number (%)
  2. Group C Control group, Group L Lidocaine group, Group D Dexmedetomidine group, Group LD Lidocaine combined with dexmedetomidine group, BMI Body mass index, ASA American society of anesthesiologists, PONV Postoperative nausea and vomiting
  3. *P versus Group C, ✩P versus Group L, #P versus Group D